New ESA To Be Available for Dialysis Patients
April 2, 2012
Peginesatide, an erythropoiesis-stimulating agent (ESA) intended for once-a-month treatment of anemia due to chronic kidney disease, has been approved for use in adults undergoing dialysis,
